Last reviewed · How we verify

NCT05859516

Application of Point-of-care Ultrasound in Rapid Assessment of Cardiac Arrest Patients

Status unknown Last updated 16 May 2023
What this trial tests

trial testing Ultrasound in Cardiac Arrest in 50 participants. Status unknown.

Timeline
1 February 2023
Primary endpoint
31 January 2024
30 June 2024

Quick facts

Lead sponsorZhongnan Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment50
Start date1 February 2023
Primary completion31 January 2024
Estimated completion30 June 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhongnan Hospital

Who can join

18 and older, any sex, with Cardiac Arrest or Point-of-care Ultrasound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To quickly assess the patient's cardiac function and structure through ultrasound

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Non-invasive Monitor of Effective Chest Compressions with Carotid and Femoral Artery Ultrasound in the Emergency Department.
    Yang F, Zou H, Gan J, Zhao X, et al · · 2025 · cited 2× · PMID 40561971 · DOI 10.5811/westjem.36710

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Cardiac Arrest

Currently open trials in the same condition.

Other Zhongnan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05859516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing